EUVIMEDEUVIMED entdecken
Crossref

The effects of enoxaparin treatment in a xenograft mouse model of oral squamous cell carcinoma: A pilot study

Yeliz Ekici iD, Merva Soluk-Tekkesin iD, Umut Can Küçüksezer, Hazal Banu Olgun Celebioglu, Erman Bulent Tuncer, Elcin Bedeloglu, Feyza Nur Tuncer iD

Journal of Oral Pathology & Medicine · 2024

DOI: 10.1111/jop.13563 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2024. Verfasst von Yeliz Ekici und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Health Sciences, Istanbul University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Enoxaparin, Mouth Neoplasms, Carcinoma, Squamous Cell, Cell Proliferation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Scientific Research Projects Coordination Unit of Istanbul University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent studies suggest that enoxaparin may have therapeutic effects on oral squamous cell carcinoma. We aimed to assess this effect utilizing xenograft mouse model through evaluations of proliferation and angiogenesis markers at the RNA and protein levels.

Methods

Mice were divided into enoxaparin treatment ( n = 4), positive control ( n = 4) and negative control ( n = 3) groups. Immunohistochemical analyses were performed utilizing Bcl‐2, Bax and Ki‐67 antibodies. Expression levels of proliferation and apoptosis related genes were calculated utilizing qRT‐PCR. Time‐dependent proliferation assays were performed in OSC‐19 and HEK293 cell‐lines.

Results

Bax antibody showed positive staining in the cytoplasm and nuclei of tumor cells, while Bcl‐2 antibody displayed staining only in the cytoplasm. A proliferation index of 15%–20% was found in all groups with the Ki‐67 marker indicating no metastasis. Enoxaparin treatment caused decrease in BCL2 , BAX and CCNB1 genes' expressions. Compared to HEK293, proliferation assays demonstrated higher division rates in OSC‐19 with a significant decrease in viability after 96 h.

Conclusion

Reduced BCL‐2 expression indicates a regression of tumor growth, but reduced BAX expression is not correlated with increased apoptosis. Despite the aggressive nature of OSC‐19, our results showed a low cell viability with a high division rate when compared with the control HEK293. This paralleled our in vivo findings that showed absence of lymph node metastasis across all mice groups. This discrepancy with the literature suggests that further investigations of the underlying mechanisms and protein‐level analyses are needed to draw definitive conclusions about the effect of enoxaparin on OSC‐19 behavior.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EnoxaparinMouth NeoplasmsCarcinoma, Squamous CellCell ProliferationAnimalsPilot ProjectsHumansMiceProto-Oncogene Proteins c-bcl-2Apoptosisbcl-2-Associated X ProteinDisease Models, AnimalKi-67 AntigenCell Line, TumorHEK293 CellsXenograft Model Antitumor AssaysCyclin B1Mice, NudeHeterografts

Stichwörter der Autor:innen

enoxaparingene expressionoral squamous cell carcinomaproliferationxenograft mouse model

Substanzen

EnoxaparinProto-Oncogene Proteins c-bcl-2bcl-2-Associated X ProteinKi-67 AntigenCyclin B1

Autor:innen und Institutionen

  • Graduate School of Health Sciences, Istanbul University, Istanbul, Turkey.
  • Department of Oral Pathology, Faculty of Dentistry, Istanbul University, Istanbul, Turkey.
  • Department of Immunology, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.
  • Department of Prosthetic Dentistry, Faculty of Dentistry, Istanbul Aydin University, Istanbul, Turkey.
  • Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Istanbul Aydin University, Istanbul, Turkey.

ORCID-Profile: Yeliz Ekici, Merva Soluk-Tekkesin, Feyza Nur Tuncer

Förderung

  • Scientific Research Projects Coordination Unit of Istanbul University

Zitieren

APA

Ekici, Y., Soluk-Tekkesin, M., Küçüksezer, U. C., Celebioglu, H. B. O., Tuncer, E. B., Bedeloglu, E., & Tuncer, F. N. (2024). The effects of enoxaparin treatment in a xenograft mouse model of oral squamous cell carcinoma: A pilot study. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.13563

Vancouver

Ekici Y, Soluk-Tekkesin M, Küçüksezer UC, Celebioglu HBO, Tuncer EB, Bedeloglu E, et al. The effects of enoxaparin treatment in a xenograft mouse model of oral squamous cell carcinoma: A pilot study. Journal of Oral Pathology & Medicine. 2024. doi:10.1111/jop.13563

BibTeX
@article{Ekici2024,
  author = {Ekici, Yeliz and Soluk-Tekkesin, Merva and Küçüksezer, Umut Can and Celebioglu, Hazal Banu Olgun and Tuncer, Erman Bulent and Bedeloglu, Elcin and Tuncer, Feyza Nur},
  title = {The effects of enoxaparin treatment in a xenograft mouse model of oral squamous cell carcinoma: A pilot study},
  journal = {Journal of Oral Pathology & Medicine},
  year = {2024},
  doi = {10.1111/jop.13563}
}
Kostenlos starten →